TS. Lương Thị Xuân Quỳnh

Hồ sơ giảng viên Faculty Profile
TS. Lương Thị Xuân Quỳnh

TS. Lương Thị Xuân Quỳnh Lương Thị Xuân Quỳnh

Học vị: Tiến sĩ

Chức danh chuyên môn: Viên chức giảng dạy

Bộ môn: Khoa học y sinh và Dược lý

Chuyên môn: Công nghệ sinh học tích hợp

Email: luongthixuanquynh@tdtu.edu.vn

Academic degree: Doctor

Academic title: Lecturer

Department: Department of Biomedical Science and Pharmacology

Specialization: Integrative Biotechnology

Email: luongthixuanquynh@tdtu.edu.vn

Google Scholar ORCID Web of Science
 

🔬 Hướng nghiên cứu chính 🔬 Main Research Directions

  • Hướng nghiên cứu: Đánh giá hoạt tính sinh học và tiềm năng của dược liệu, protein tái tổ hợp
  • Research interests: Biological activities of natural products, recombinant proteins

🧑‍🏫 Các môn giảng dạy tiêu biểu 🧑‍🏫 Teaching Subjects

  • Sinh học tế bào
  • Công nghệ sinh học Dược
  • Cell Biology
  • Pharmaceutical Biotechnology

🎓 Quá trình đào tạo 🎓 Education

  • 2024: Tiến sĩ chuyên ngành Công nghệ sinh học tích hợp, Đại học Sungkyunkwan, Hàn Quốc.
  • 2018: Thạc sĩ chuyên ngành Công nghệ sinh học, Đại học Nông Lâm, TP. Hồ Chí Minh.
  • 2015: Cử nhân Công nghệ sinh học, Đại học Nông Lâm, TP. Hồ Chí
  • 2024: Doctor of Integrative Biotechnology; Sungkyunkwan University, Korea
  • 2018: Master of Biotechnology, Nong Lam University, Ho Chi Minh city
  • 2015: Bachelor of Biotechnology, Nong Lam University, Ho Chi Minh city

🏢 Quá trình công tác 🏢 Professional Experience

  • 06/2025-nay: Khoa Dược, Đại học Tôn Đức Thắng
  • 06/2025-present: Faculty of Pharmacy, Ton Duc Thang University

📑 Công bố khoa học 📑 Publications

    1. Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong Thi Ho, Ramadhani Qurrota Ayun, Taek Kyun Lee, Sukchan Lee. 2025. Potential broad-spectrum antiviral agents: A key arsenal against newly emerging and reemerging respiratory RNA viruses. International Journal of Molecular Sciences, 26(4): p. 1481.
    2. Quynh Xuan Thi Luong, Phuong Thi Hoang, Yongjun Lee, Ramadhani Qurrota Ayun, Kyungho Na, Seonhyeon Park, Chengmin Lin, Phuong Thi Ho, Taek Kyun Lee, Sukchan Lee. 2024. An RNA-hydrolyzing recombinant minibody prevents both influenza A virus and coronavirus in co-infection models. Scientific Reports, 14(1): p. 8472.
    3. Phuong Thi Hoang*, Quynh Xuan Thi Luong*, Ramadhani Qurrota Ayun, Yongjun Lee, Thuy Thi Bich Vo, Taehyun Kim, Sukchan Lee. 2022. A novel approach of antiviral drugs targeting viral genomes. Microorganisms, 10(8): p. 1552. *Equal contribution
    4. Phuong Thi Hoang, Quynh Xuan Thi Luong, Ramadhani Qurrota Ayun, Yongjun Lee, Kwang-Ji Oh, Taehyun Kim, Taek Kyun Lee, and Sukchan Lee. 2024. A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain VL and an RNA hydrolyzing scFv. Frontiers in microbiology, 15: 1355599.
    5. Phuong Thi Hoang, Quynh Xuan Thi Luong, Seungchan Cho, Yongjun Lee, Kyungho Na, Ramadhani Qurrota Ayun, Thuy Thi Bich Vo, Taehyun Kim, and Sukchan Lee. 2022. Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form. Plos One, 17(8): p. e0273934.
    6. Phuong T. Ho, Eulyong Park, Quynh Xuan Thi Luong, Meutia Diva Hakim, Phuong T. Hoang, Thuy T. B. Vo, Kantawong Kawalin, Hee Kang, Taek- Kyun Lee, and Sukchan Lee. 2024. Amelioration of cancer cachexia by Dalbergia odorifera extract through AKT signaling pathway regulation. Nutrients, 16(21): 3671.
    7. Yongjun Lee*, Phuong Thi Hoang*, Dongjun Kim, Ramadhani Qurrota Ayun, Quynh Xuan Thi Luong, Kyungho Na, Taehyun Kim, Yeonsu Oh, Won-Keun Kim, and Sukchan Lee. 2021. A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs. Viruses, 2022. 14(5).
    1. Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong Thi Ho, Ramadhani Qurrota Ayun, Taek Kyun Lee, Sukchan Lee. 2025. Potential broad-spectrum antiviral agents: A key arsenal against newly emerging and reemerging respiratory RNA viruses. International Journal of Molecular Sciences, 26(4): p. 1481.
    2. Quynh Xuan Thi Luong, Phuong Thi Hoang, Yongjun Lee, Ramadhani Qurrota Ayun, Kyungho Na, Seonhyeon Park, Chengmin Lin, Phuong Thi Ho, Taek Kyun Lee, Sukchan Lee. 2024. An RNA-hydrolyzing recombinant minibody prevents both influenza A virus and coronavirus in co-infection models. Scientific Reports, 14(1): p. 8472.
    3. Phuong Thi Hoang*, Quynh Xuan Thi Luong*, Ramadhani Qurrota Ayun, Yongjun Lee, Thuy Thi Bich Vo, Taehyun Kim, Sukchan Lee. 2022. A novel approach of antiviral drugs targeting viral genomes. Microorganisms, 10(8): p. 1552. *Equal contribution
    4. Phuong Thi Hoang, Quynh Xuan Thi Luong, Ramadhani Qurrota Ayun, Yongjun Lee, Kwang-Ji Oh, Taehyun Kim, Taek Kyun Lee, and Sukchan Lee. 2024. A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain VL and an RNA hydrolyzing scFv. Frontiers in microbiology, 15: 1355599.
    5. Phuong Thi Hoang, Quynh Xuan Thi Luong, Seungchan Cho, Yongjun Lee, Kyungho Na, Ramadhani Qurrota Ayun, Thuy Thi Bich Vo, Taehyun Kim, and Sukchan Lee. 2022. Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form. Plos One, 17(8): p. e0273934.
    6. Phuong T. Ho, Eulyong Park, Quynh Xuan Thi Luong, Meutia Diva Hakim, Phuong T. Hoang, Thuy T. B. Vo, Kantawong Kawalin, Hee Kang, Taek- Kyun Lee, and Sukchan Lee. 2024. Amelioration of cancer cachexia by Dalbergia odorifera extract through AKT signaling pathway regulation. Nutrients, 16(21): 3671.
    7. Yongjun Lee*, Phuong Thi Hoang*, Dongjun Kim, Ramadhani Qurrota Ayun, Quynh Xuan Thi Luong, Kyungho Na, Taehyun Kim, Yeonsu Oh, Won-Keun Kim, and Sukchan Lee. 2021. A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs. Viruses, 2022. 14(5).